Literature DB >> 11074130

Early treatment of endometriosis with GnRH-agonists: impact on time to recurrence.

A E Schindler1, P Foertig, E Kienle, P A Regidor.   

Abstract

In a study, 52 patients with histologically confirmed endometriosis underwent a "three-step" therapy. The follow-up period was up to 60 months (median 33.5 months). If r-AFS-score was posttherapeutically 0, recurrence occurred latest after 36 months (median 18 months), if stage III was found posttherapeutically, recurrence occurred already latest after 18 months (median 8 months), (log-rank test P=0.0072). In our study we could confirm a clear relationship of recurrence of symptomatic endometriosis to the post-therapeutically achieved r-AFS-score.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074130     DOI: 10.1016/s0301-2115(00)00244-x

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruation†.

Authors:  Aya Tal; Reshef Tal; Nicola Pluchino; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

2.  Effects of simvastatin in prevention of pain recurrences after surgery for endometriosis.

Authors:  Fariba Almassinokiani; Abolfazl Mehdizadeh; Elahe Sariri; Mansour Rezaei; Alireza Almasi; Hossein Akbari; Abdolreza Pazooki; Masoud Solaymani-Dodaran; Sara Asadollah; Jila Amirkhani; Shahla Chaichian; Mansoureh Vahdat; Ashrafsadat Moosavi; Monir Ashouri; Zeinab Tamannaei
Journal:  Med Sci Monit       Date:  2013-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.